Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.03
Delayed Data
As of 3:59pm ET
 -0.18 / -2.19%
Today’s Change
4.60
Today|||52-Week Range
8.48
+2.03%
Year-to-Date

Today’s Trading

Previous close8.21
Today’s open8.17
Day’s range7.80 - 8.23
Volume391,278
Average volume (3 months)318,178
Market cap$633.1M
Dividend yield--
Data as of 3:59pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+105.56%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
NVTAInvitae Corp-0.41-4.35%
GNMKGenMark Diagnostics ...-0.07-1.23%
RDNTRadNet Inc+0.15+2.98%
CCMConcord Medical Serv...+0.01+0.21%
Data as of 4:02pm ET, 05/04/2016

Financials

Next reporting dateJuly 14, 2016
EPS forecast (this quarter)$0.02
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs